TABLE 2.

Comparison of PANSS between the mentioned groups of drugs.

	Risperidone (Median or Mean ± SD)	Clozapine (Median or Mean ± SD)	Aripiprazole (Median or Mean ± SD)	ANOVA or Kruslal-Wallis	pa	pb	pc
PANSS Total	68.5	67.0	68.0	0.630	0.363	0.516	0.714
PANSS Positive	16.5	15.0	15.0	0.333	0.174	0.233	0.933
PANSS Negative	15.0	14.0	15.0	0.353	0.166	0.304	0.705
PANSS General	39.10 ± 7.43	37.50 ± 5.87	38.55 ± 7.32	0.759	0.745	0.966	0.881

The Shapiro-Wilk normality test. One-factor ANOVA or Kruskal-Wallis test was used. For subsequent tests within ANOVA, post-processing with the Tukey test was applied. Mann-Whitney U test. Bonferroni correction (we will consider the results of subsequent tests to be statistically significant if the p value is less than 0.017). In the part of descriptive statistical analysis, average values and standard deviation for data that follow the normal distribution and median values for data that do not follow the normal distribution are shown.

PANSS, Positive and Negative Syndrome Scale; p^a: Risperidone vs. Clozapine group; p^b: Risperidone vs. Aripiprazole group; p^c: Clozapine vs. Aripiprazole group.